Literature DB >> 22465143

Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.

Hagit Goldenstein1, Nina S Levy, Andrew P Levy.   

Abstract

Haptoglobin (Hp) is a hemoglobin (Hb) binding protein whose major function is to prevent heme-iron mediated oxidation. The polymorphic nature of the Hp gene results in varying levels of antioxidant function associated with the protein products. Multiple clinical studies have now determined that the Hp 2-2 genotype is associated with an increased risk of developing vascular complications in patients suffering from diabetes. The mechanism for this phenomenon is a decrease in antioxidant capability associated with the Hp 2-2 protein. Specifically, heme iron associated with the Hp2-2/Hb complex is more redox active than other Hp type complexes and has been shown in a number of systems to lead to increased levels of oxidative stress in the form of oxidized lipids and decreased lipoprotein function. In addition, Hp 2-2/Hb complexes are cleared less efficiently from the circulation, leading to a buildup of iron in the plasma and in tissues. Recent analyses from clinical studies utilizing vitamin E treatment have shown beneficial results specifically in the diabetic Hp 2-2 genotype population. The use of vitamin E in the treatment of Hp 2-2 diabetics has the potential to greatly reduce medical costs and improve quality of life in the ever-growing diabetic population.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465143      PMCID: PMC3345090          DOI: 10.1016/j.phrs.2012.02.011

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  38 in total

Review 1.  Redox reactions of hemoglobin.

Authors:  Joseph M Rifkind; Somasundaram Ramasamy; P T Manoharan; Enika Nagababu; Joy G Mohanty
Journal:  Antioxid Redox Signal       Date:  2004-06       Impact factor: 8.401

2.  Vitamin E supplementation and cardiovascular events in high-risk patients.

Authors:  S Yusuf; G Dagenais; J Pogue; J Bosch; P Sleight
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

Authors:  Andrew P Levy; Irit Hochberg; Kathleen Jablonski; Helaine E Resnick; Elisa T Lee; Lyle Best; Barbara V Howard
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

4.  Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  A Roguin; I Hochberg; E Nikolsky; W Markiewicz; S R Meisel; J Hir; E Grenadier; R Beyar; A P Levy
Journal:  Am J Cardiol       Date:  2001-02-01       Impact factor: 2.778

5.  Structure-function analysis of the antioxidant properties of haptoglobin.

Authors:  M Melamed-Frank; O Lache; B I Enav; T Szafranek; N S Levy; R M Ricklis; A P Levy
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

6.  Haptoglobin phenotype and diabetic nephropathy.

Authors:  F M Nakhoul; R Zoabi; Y Kanter; M Zoabi; K Skorecki; I Hochberg; R Leibu; B Miller; A P Levy
Journal:  Diabetologia       Date:  2001-05       Impact factor: 10.122

7.  Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid.

Authors:  M Balestrieri; L Cigliano; M L Simone; B Dale; P Abrescia
Journal:  Mol Reprod Dev       Date:  2001-06       Impact factor: 2.609

8.  Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.

Authors:  Ariel Roguin; Werner Koch; Adnan Kastrati; Doron Aronson; Albert Schomig; Andrew P Levy
Journal:  Diabetes Care       Date:  2003-09       Impact factor: 19.112

9.  Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL.

Authors:  Vladimir V Bamm; Vladimir A Tsemakhovich; Matityahu Shaklai; Nurith Shaklai
Journal:  Biochemistry       Date:  2004-04-06       Impact factor: 3.162

10.  Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.

Authors:  Melissa Simpson; Janet K Snell-Bergeon; Gregory L Kinney; Orit Lache; Rachel Miller-Lotan; Yefim Anbinder; Marian J Rewers; Andrew P Levy
Journal:  Cardiovasc Diabetol       Date:  2011-11-20       Impact factor: 9.951

View more
  20 in total

1.  Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer.

Authors:  Kamil Brzóska; Teresa Bartłomiejczyk; Barbara Sochanowicz; Magdalena Cymerman; Jacek Grudny; Jacek Kołakowski; Marcin Kruszewski; Paweł Śliwiński; Kazimierz Roszkowski-Śliż; Lucyna Kapka-Skrzypczak
Journal:  Oncol Lett       Date:  2018-09-19       Impact factor: 2.967

2.  Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage.

Authors:  Jenna L Leclerc; Spiros Blackburn; Dan Neal; Nicholas V Mendez; Jeffrey A Wharton; Michael F Waters; Sylvain Doré
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

3.  Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin.

Authors:  Todd L Mollan; Yiping Jia; Sambuddha Banerjee; Gang Wu; R Timothy Kreulen; Ah-Lim Tsai; John S Olson; Alvin L Crumbliss; Abdu I Alayash
Journal:  Free Radic Biol Med       Date:  2014-01-30       Impact factor: 7.376

Review 4.  Patient selection and vitamin E treatment in diabetes mellitus.

Authors:  Hagit Goldenstein; Nina S Levy; Yisrael T Lipener; Andrew P Levy
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-03

Review 5.  Human genetic variation influences vitamin C homeostasis by altering vitamin C transport and antioxidant enzyme function.

Authors:  Alexander J Michels; Tory M Hagen; Balz Frei
Journal:  Annu Rev Nutr       Date:  2013-04-29       Impact factor: 11.848

6.  Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.

Authors:  Niyati U Mehta; Victor Grijalva; Susan Hama; Alan Wagner; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-14       Impact factor: 8.311

Review 7.  Atherogenesis and iron: from epidemiology to cellular level.

Authors:  Francesca Vinchi; Martina U Muckenthaler; Milene C Da Silva; György Balla; József Balla; Viktória Jeney
Journal:  Front Pharmacol       Date:  2014-05-05       Impact factor: 5.810

Review 8.  Red blood cell, hemoglobin and heme in the progression of atherosclerosis.

Authors:  Viktória Jeney; György Balla; József Balla
Journal:  Front Physiol       Date:  2014-10-02       Impact factor: 4.566

Review 9.  Natural history of the bruise: formation, elimination, and biological effects of oxidized hemoglobin.

Authors:  Viktória Jeney; John W Eaton; György Balla; József Balla
Journal:  Oxid Med Cell Longev       Date:  2013-05-16       Impact factor: 6.543

10.  Haptoglobin: an emerging candidate for phenotypic modulation of sickle cell anemia?

Authors:  Magnun Nueldo Nunes Dos Santos
Journal:  Rev Bras Hematol Hemoter       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.